BMS Speeds Expansion Into Neuroscience With $14bn Karuna Buy

Schizophrenia Drug Approval Expected In September

 
• By Mandy Jackson
  
Abstract human brain. Artificial intelligence new technology. Science futuristic background
Bristol will go from a few Phase II-ready neuroscience programs to multiple late-stage trials • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business